| Dr Kevin Allen Davis, MD | |
|
7301 Rogers Ave, Fort Smith, AR 72903-4100 | |
| (501) 593-3845 | |
| Not Available |
| Full Name | Dr Kevin Allen Davis |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 11 Years |
| Location | 7301 Rogers Ave, Fort Smith, Arkansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033452990 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | E-10206 (Arkansas) | Secondary |
| 207RI0200X | Internal Medicine - Infectious Disease | E-10206 (Arkansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercy Hospital Fort Smith | Fort smith, AR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mercy Clinic Fort Smith Communities | 3870668510 | 273 |
News Archive
So disease-causing bacteria in the body finally have multiplied to the point where their numbers are large enough to cause illness. What's next? They get out their "smart phones" and whisper "Let's roll!" That's how an article in ACS' monthly Chemical Reviews describes the substances "smart phones of the microbial world" that bacteria use to transmit chemical signals that launch infections and monitor their environment.
Researchers at The Ohio State University Ross Heart Hospital and Nationwide Children's Hospital have shown early treatment with the heart failure medication eplerenone can improve heart function in young boys with Duchenne muscular dystrophy (DMD) and stabilize heart function in older boys with the disease.
New research published in the November 4, 2008 issue of Neurology, the medical journal of the American Academy of Neurology, found that ADHD affects the motor skills of boys more than girls. By examining age-related improvement of motor skills in children with and without ADHD, researchers from the Kennedy Krieger Institute in Baltimore, Md. found that girls with ADHD and their typically developing peers were more likely to be able to control their movements compared to boys with ADHD.
Altair Therapeutics, Inc., a privately-held, biopharmaceutical company developing novel therapeutics for respiratory diseases, today announced the commencement of its IL-4 receptor alpha inhibitor bronchoprovocation trial. Study AIR645-CS2 is a phase 2, multi-center, randomized, double-blind, placebo-controlled study to assess the safety, tolerability, and efficacy of inhaled AIR645 in suppressing the asthmatic response in subjects with mild asthma. Results are expected in the third quarter of 2010.
Janssen-Cilag International NV today announced that its next generation protease inhibitor (PI) OLYSIOTM (simeprevir) has been granted marketing authorisation by the European Commission (EC) for the treatment of adults with genotype 1 and 4 chronic hepatitis C (CHC), in combination with other medicinal products.
› Verified 7 days ago
| Entity Name | Mercy Hospital Waldron |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730137134 PECOS PAC ID: 5597658005 Enrollment ID: O20040211000825 |
News Archive
So disease-causing bacteria in the body finally have multiplied to the point where their numbers are large enough to cause illness. What's next? They get out their "smart phones" and whisper "Let's roll!" That's how an article in ACS' monthly Chemical Reviews describes the substances "smart phones of the microbial world" that bacteria use to transmit chemical signals that launch infections and monitor their environment.
Researchers at The Ohio State University Ross Heart Hospital and Nationwide Children's Hospital have shown early treatment with the heart failure medication eplerenone can improve heart function in young boys with Duchenne muscular dystrophy (DMD) and stabilize heart function in older boys with the disease.
New research published in the November 4, 2008 issue of Neurology, the medical journal of the American Academy of Neurology, found that ADHD affects the motor skills of boys more than girls. By examining age-related improvement of motor skills in children with and without ADHD, researchers from the Kennedy Krieger Institute in Baltimore, Md. found that girls with ADHD and their typically developing peers were more likely to be able to control their movements compared to boys with ADHD.
Altair Therapeutics, Inc., a privately-held, biopharmaceutical company developing novel therapeutics for respiratory diseases, today announced the commencement of its IL-4 receptor alpha inhibitor bronchoprovocation trial. Study AIR645-CS2 is a phase 2, multi-center, randomized, double-blind, placebo-controlled study to assess the safety, tolerability, and efficacy of inhaled AIR645 in suppressing the asthmatic response in subjects with mild asthma. Results are expected in the third quarter of 2010.
Janssen-Cilag International NV today announced that its next generation protease inhibitor (PI) OLYSIOTM (simeprevir) has been granted marketing authorisation by the European Commission (EC) for the treatment of adults with genotype 1 and 4 chronic hepatitis C (CHC), in combination with other medicinal products.
› Verified 7 days ago
| Entity Name | Mercy Hospital Ozark |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881642767 PECOS PAC ID: 3678467412 Enrollment ID: O20040211001144 |
News Archive
So disease-causing bacteria in the body finally have multiplied to the point where their numbers are large enough to cause illness. What's next? They get out their "smart phones" and whisper "Let's roll!" That's how an article in ACS' monthly Chemical Reviews describes the substances "smart phones of the microbial world" that bacteria use to transmit chemical signals that launch infections and monitor their environment.
Researchers at The Ohio State University Ross Heart Hospital and Nationwide Children's Hospital have shown early treatment with the heart failure medication eplerenone can improve heart function in young boys with Duchenne muscular dystrophy (DMD) and stabilize heart function in older boys with the disease.
New research published in the November 4, 2008 issue of Neurology, the medical journal of the American Academy of Neurology, found that ADHD affects the motor skills of boys more than girls. By examining age-related improvement of motor skills in children with and without ADHD, researchers from the Kennedy Krieger Institute in Baltimore, Md. found that girls with ADHD and their typically developing peers were more likely to be able to control their movements compared to boys with ADHD.
Altair Therapeutics, Inc., a privately-held, biopharmaceutical company developing novel therapeutics for respiratory diseases, today announced the commencement of its IL-4 receptor alpha inhibitor bronchoprovocation trial. Study AIR645-CS2 is a phase 2, multi-center, randomized, double-blind, placebo-controlled study to assess the safety, tolerability, and efficacy of inhaled AIR645 in suppressing the asthmatic response in subjects with mild asthma. Results are expected in the third quarter of 2010.
Janssen-Cilag International NV today announced that its next generation protease inhibitor (PI) OLYSIOTM (simeprevir) has been granted marketing authorisation by the European Commission (EC) for the treatment of adults with genotype 1 and 4 chronic hepatitis C (CHC), in combination with other medicinal products.
› Verified 7 days ago
| Entity Name | Arkansas Childrens Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598773079 PECOS PAC ID: 2769477744 Enrollment ID: O20040419000796 |
News Archive
So disease-causing bacteria in the body finally have multiplied to the point where their numbers are large enough to cause illness. What's next? They get out their "smart phones" and whisper "Let's roll!" That's how an article in ACS' monthly Chemical Reviews describes the substances "smart phones of the microbial world" that bacteria use to transmit chemical signals that launch infections and monitor their environment.
Researchers at The Ohio State University Ross Heart Hospital and Nationwide Children's Hospital have shown early treatment with the heart failure medication eplerenone can improve heart function in young boys with Duchenne muscular dystrophy (DMD) and stabilize heart function in older boys with the disease.
New research published in the November 4, 2008 issue of Neurology, the medical journal of the American Academy of Neurology, found that ADHD affects the motor skills of boys more than girls. By examining age-related improvement of motor skills in children with and without ADHD, researchers from the Kennedy Krieger Institute in Baltimore, Md. found that girls with ADHD and their typically developing peers were more likely to be able to control their movements compared to boys with ADHD.
Altair Therapeutics, Inc., a privately-held, biopharmaceutical company developing novel therapeutics for respiratory diseases, today announced the commencement of its IL-4 receptor alpha inhibitor bronchoprovocation trial. Study AIR645-CS2 is a phase 2, multi-center, randomized, double-blind, placebo-controlled study to assess the safety, tolerability, and efficacy of inhaled AIR645 in suppressing the asthmatic response in subjects with mild asthma. Results are expected in the third quarter of 2010.
Janssen-Cilag International NV today announced that its next generation protease inhibitor (PI) OLYSIOTM (simeprevir) has been granted marketing authorisation by the European Commission (EC) for the treatment of adults with genotype 1 and 4 chronic hepatitis C (CHC), in combination with other medicinal products.
› Verified 7 days ago
| Entity Name | Mercy Hospital Ozark |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1275504128 PECOS PAC ID: 3678467412 Enrollment ID: O20040428001328 |
News Archive
So disease-causing bacteria in the body finally have multiplied to the point where their numbers are large enough to cause illness. What's next? They get out their "smart phones" and whisper "Let's roll!" That's how an article in ACS' monthly Chemical Reviews describes the substances "smart phones of the microbial world" that bacteria use to transmit chemical signals that launch infections and monitor their environment.
Researchers at The Ohio State University Ross Heart Hospital and Nationwide Children's Hospital have shown early treatment with the heart failure medication eplerenone can improve heart function in young boys with Duchenne muscular dystrophy (DMD) and stabilize heart function in older boys with the disease.
New research published in the November 4, 2008 issue of Neurology, the medical journal of the American Academy of Neurology, found that ADHD affects the motor skills of boys more than girls. By examining age-related improvement of motor skills in children with and without ADHD, researchers from the Kennedy Krieger Institute in Baltimore, Md. found that girls with ADHD and their typically developing peers were more likely to be able to control their movements compared to boys with ADHD.
Altair Therapeutics, Inc., a privately-held, biopharmaceutical company developing novel therapeutics for respiratory diseases, today announced the commencement of its IL-4 receptor alpha inhibitor bronchoprovocation trial. Study AIR645-CS2 is a phase 2, multi-center, randomized, double-blind, placebo-controlled study to assess the safety, tolerability, and efficacy of inhaled AIR645 in suppressing the asthmatic response in subjects with mild asthma. Results are expected in the third quarter of 2010.
Janssen-Cilag International NV today announced that its next generation protease inhibitor (PI) OLYSIOTM (simeprevir) has been granted marketing authorisation by the European Commission (EC) for the treatment of adults with genotype 1 and 4 chronic hepatitis C (CHC), in combination with other medicinal products.
› Verified 7 days ago
| Entity Name | Mercy Hospital Waldron |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1912978875 PECOS PAC ID: 5597658005 Enrollment ID: O20061104000294 |
News Archive
So disease-causing bacteria in the body finally have multiplied to the point where their numbers are large enough to cause illness. What's next? They get out their "smart phones" and whisper "Let's roll!" That's how an article in ACS' monthly Chemical Reviews describes the substances "smart phones of the microbial world" that bacteria use to transmit chemical signals that launch infections and monitor their environment.
Researchers at The Ohio State University Ross Heart Hospital and Nationwide Children's Hospital have shown early treatment with the heart failure medication eplerenone can improve heart function in young boys with Duchenne muscular dystrophy (DMD) and stabilize heart function in older boys with the disease.
New research published in the November 4, 2008 issue of Neurology, the medical journal of the American Academy of Neurology, found that ADHD affects the motor skills of boys more than girls. By examining age-related improvement of motor skills in children with and without ADHD, researchers from the Kennedy Krieger Institute in Baltimore, Md. found that girls with ADHD and their typically developing peers were more likely to be able to control their movements compared to boys with ADHD.
Altair Therapeutics, Inc., a privately-held, biopharmaceutical company developing novel therapeutics for respiratory diseases, today announced the commencement of its IL-4 receptor alpha inhibitor bronchoprovocation trial. Study AIR645-CS2 is a phase 2, multi-center, randomized, double-blind, placebo-controlled study to assess the safety, tolerability, and efficacy of inhaled AIR645 in suppressing the asthmatic response in subjects with mild asthma. Results are expected in the third quarter of 2010.
Janssen-Cilag International NV today announced that its next generation protease inhibitor (PI) OLYSIOTM (simeprevir) has been granted marketing authorisation by the European Commission (EC) for the treatment of adults with genotype 1 and 4 chronic hepatitis C (CHC), in combination with other medicinal products.
› Verified 7 days ago
| Entity Name | Mercy Hospital Paris |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1760453633 PECOS PAC ID: 0244135705 Enrollment ID: O20061104000304 |
News Archive
So disease-causing bacteria in the body finally have multiplied to the point where their numbers are large enough to cause illness. What's next? They get out their "smart phones" and whisper "Let's roll!" That's how an article in ACS' monthly Chemical Reviews describes the substances "smart phones of the microbial world" that bacteria use to transmit chemical signals that launch infections and monitor their environment.
Researchers at The Ohio State University Ross Heart Hospital and Nationwide Children's Hospital have shown early treatment with the heart failure medication eplerenone can improve heart function in young boys with Duchenne muscular dystrophy (DMD) and stabilize heart function in older boys with the disease.
New research published in the November 4, 2008 issue of Neurology, the medical journal of the American Academy of Neurology, found that ADHD affects the motor skills of boys more than girls. By examining age-related improvement of motor skills in children with and without ADHD, researchers from the Kennedy Krieger Institute in Baltimore, Md. found that girls with ADHD and their typically developing peers were more likely to be able to control their movements compared to boys with ADHD.
Altair Therapeutics, Inc., a privately-held, biopharmaceutical company developing novel therapeutics for respiratory diseases, today announced the commencement of its IL-4 receptor alpha inhibitor bronchoprovocation trial. Study AIR645-CS2 is a phase 2, multi-center, randomized, double-blind, placebo-controlled study to assess the safety, tolerability, and efficacy of inhaled AIR645 in suppressing the asthmatic response in subjects with mild asthma. Results are expected in the third quarter of 2010.
Janssen-Cilag International NV today announced that its next generation protease inhibitor (PI) OLYSIOTM (simeprevir) has been granted marketing authorisation by the European Commission (EC) for the treatment of adults with genotype 1 and 4 chronic hepatitis C (CHC), in combination with other medicinal products.
› Verified 7 days ago
| Entity Name | Baxter County Regional Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447420997 PECOS PAC ID: 0042389264 Enrollment ID: O20080514000435 |
News Archive
So disease-causing bacteria in the body finally have multiplied to the point where their numbers are large enough to cause illness. What's next? They get out their "smart phones" and whisper "Let's roll!" That's how an article in ACS' monthly Chemical Reviews describes the substances "smart phones of the microbial world" that bacteria use to transmit chemical signals that launch infections and monitor their environment.
Researchers at The Ohio State University Ross Heart Hospital and Nationwide Children's Hospital have shown early treatment with the heart failure medication eplerenone can improve heart function in young boys with Duchenne muscular dystrophy (DMD) and stabilize heart function in older boys with the disease.
New research published in the November 4, 2008 issue of Neurology, the medical journal of the American Academy of Neurology, found that ADHD affects the motor skills of boys more than girls. By examining age-related improvement of motor skills in children with and without ADHD, researchers from the Kennedy Krieger Institute in Baltimore, Md. found that girls with ADHD and their typically developing peers were more likely to be able to control their movements compared to boys with ADHD.
Altair Therapeutics, Inc., a privately-held, biopharmaceutical company developing novel therapeutics for respiratory diseases, today announced the commencement of its IL-4 receptor alpha inhibitor bronchoprovocation trial. Study AIR645-CS2 is a phase 2, multi-center, randomized, double-blind, placebo-controlled study to assess the safety, tolerability, and efficacy of inhaled AIR645 in suppressing the asthmatic response in subjects with mild asthma. Results are expected in the third quarter of 2010.
Janssen-Cilag International NV today announced that its next generation protease inhibitor (PI) OLYSIOTM (simeprevir) has been granted marketing authorisation by the European Commission (EC) for the treatment of adults with genotype 1 and 4 chronic hepatitis C (CHC), in combination with other medicinal products.
› Verified 7 days ago
| Entity Name | Mercy Clinic Fort Smith Communities |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902073620 PECOS PAC ID: 3870668510 Enrollment ID: O20080814000789 |
News Archive
So disease-causing bacteria in the body finally have multiplied to the point where their numbers are large enough to cause illness. What's next? They get out their "smart phones" and whisper "Let's roll!" That's how an article in ACS' monthly Chemical Reviews describes the substances "smart phones of the microbial world" that bacteria use to transmit chemical signals that launch infections and monitor their environment.
Researchers at The Ohio State University Ross Heart Hospital and Nationwide Children's Hospital have shown early treatment with the heart failure medication eplerenone can improve heart function in young boys with Duchenne muscular dystrophy (DMD) and stabilize heart function in older boys with the disease.
New research published in the November 4, 2008 issue of Neurology, the medical journal of the American Academy of Neurology, found that ADHD affects the motor skills of boys more than girls. By examining age-related improvement of motor skills in children with and without ADHD, researchers from the Kennedy Krieger Institute in Baltimore, Md. found that girls with ADHD and their typically developing peers were more likely to be able to control their movements compared to boys with ADHD.
Altair Therapeutics, Inc., a privately-held, biopharmaceutical company developing novel therapeutics for respiratory diseases, today announced the commencement of its IL-4 receptor alpha inhibitor bronchoprovocation trial. Study AIR645-CS2 is a phase 2, multi-center, randomized, double-blind, placebo-controlled study to assess the safety, tolerability, and efficacy of inhaled AIR645 in suppressing the asthmatic response in subjects with mild asthma. Results are expected in the third quarter of 2010.
Janssen-Cilag International NV today announced that its next generation protease inhibitor (PI) OLYSIOTM (simeprevir) has been granted marketing authorisation by the European Commission (EC) for the treatment of adults with genotype 1 and 4 chronic hepatitis C (CHC), in combination with other medicinal products.
› Verified 7 days ago
| Entity Name | Mercy Hospital Paris |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518915321 PECOS PAC ID: 0244135705 Enrollment ID: O20090402000673 |
News Archive
So disease-causing bacteria in the body finally have multiplied to the point where their numbers are large enough to cause illness. What's next? They get out their "smart phones" and whisper "Let's roll!" That's how an article in ACS' monthly Chemical Reviews describes the substances "smart phones of the microbial world" that bacteria use to transmit chemical signals that launch infections and monitor their environment.
Researchers at The Ohio State University Ross Heart Hospital and Nationwide Children's Hospital have shown early treatment with the heart failure medication eplerenone can improve heart function in young boys with Duchenne muscular dystrophy (DMD) and stabilize heart function in older boys with the disease.
New research published in the November 4, 2008 issue of Neurology, the medical journal of the American Academy of Neurology, found that ADHD affects the motor skills of boys more than girls. By examining age-related improvement of motor skills in children with and without ADHD, researchers from the Kennedy Krieger Institute in Baltimore, Md. found that girls with ADHD and their typically developing peers were more likely to be able to control their movements compared to boys with ADHD.
Altair Therapeutics, Inc., a privately-held, biopharmaceutical company developing novel therapeutics for respiratory diseases, today announced the commencement of its IL-4 receptor alpha inhibitor bronchoprovocation trial. Study AIR645-CS2 is a phase 2, multi-center, randomized, double-blind, placebo-controlled study to assess the safety, tolerability, and efficacy of inhaled AIR645 in suppressing the asthmatic response in subjects with mild asthma. Results are expected in the third quarter of 2010.
Janssen-Cilag International NV today announced that its next generation protease inhibitor (PI) OLYSIOTM (simeprevir) has been granted marketing authorisation by the European Commission (EC) for the treatment of adults with genotype 1 and 4 chronic hepatitis C (CHC), in combination with other medicinal products.
› Verified 7 days ago
| Entity Name | Mercy Hospital Booneville |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1992133714 PECOS PAC ID: 1951530385 Enrollment ID: O20140312001275 |
News Archive
So disease-causing bacteria in the body finally have multiplied to the point where their numbers are large enough to cause illness. What's next? They get out their "smart phones" and whisper "Let's roll!" That's how an article in ACS' monthly Chemical Reviews describes the substances "smart phones of the microbial world" that bacteria use to transmit chemical signals that launch infections and monitor their environment.
Researchers at The Ohio State University Ross Heart Hospital and Nationwide Children's Hospital have shown early treatment with the heart failure medication eplerenone can improve heart function in young boys with Duchenne muscular dystrophy (DMD) and stabilize heart function in older boys with the disease.
New research published in the November 4, 2008 issue of Neurology, the medical journal of the American Academy of Neurology, found that ADHD affects the motor skills of boys more than girls. By examining age-related improvement of motor skills in children with and without ADHD, researchers from the Kennedy Krieger Institute in Baltimore, Md. found that girls with ADHD and their typically developing peers were more likely to be able to control their movements compared to boys with ADHD.
Altair Therapeutics, Inc., a privately-held, biopharmaceutical company developing novel therapeutics for respiratory diseases, today announced the commencement of its IL-4 receptor alpha inhibitor bronchoprovocation trial. Study AIR645-CS2 is a phase 2, multi-center, randomized, double-blind, placebo-controlled study to assess the safety, tolerability, and efficacy of inhaled AIR645 in suppressing the asthmatic response in subjects with mild asthma. Results are expected in the third quarter of 2010.
Janssen-Cilag International NV today announced that its next generation protease inhibitor (PI) OLYSIOTM (simeprevir) has been granted marketing authorisation by the European Commission (EC) for the treatment of adults with genotype 1 and 4 chronic hepatitis C (CHC), in combination with other medicinal products.
› Verified 7 days ago
| Entity Name | Mercy Hospital Booneville |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083004733 PECOS PAC ID: 1951530385 Enrollment ID: O20170203001490 |
News Archive
So disease-causing bacteria in the body finally have multiplied to the point where their numbers are large enough to cause illness. What's next? They get out their "smart phones" and whisper "Let's roll!" That's how an article in ACS' monthly Chemical Reviews describes the substances "smart phones of the microbial world" that bacteria use to transmit chemical signals that launch infections and monitor their environment.
Researchers at The Ohio State University Ross Heart Hospital and Nationwide Children's Hospital have shown early treatment with the heart failure medication eplerenone can improve heart function in young boys with Duchenne muscular dystrophy (DMD) and stabilize heart function in older boys with the disease.
New research published in the November 4, 2008 issue of Neurology, the medical journal of the American Academy of Neurology, found that ADHD affects the motor skills of boys more than girls. By examining age-related improvement of motor skills in children with and without ADHD, researchers from the Kennedy Krieger Institute in Baltimore, Md. found that girls with ADHD and their typically developing peers were more likely to be able to control their movements compared to boys with ADHD.
Altair Therapeutics, Inc., a privately-held, biopharmaceutical company developing novel therapeutics for respiratory diseases, today announced the commencement of its IL-4 receptor alpha inhibitor bronchoprovocation trial. Study AIR645-CS2 is a phase 2, multi-center, randomized, double-blind, placebo-controlled study to assess the safety, tolerability, and efficacy of inhaled AIR645 in suppressing the asthmatic response in subjects with mild asthma. Results are expected in the third quarter of 2010.
Janssen-Cilag International NV today announced that its next generation protease inhibitor (PI) OLYSIOTM (simeprevir) has been granted marketing authorisation by the European Commission (EC) for the treatment of adults with genotype 1 and 4 chronic hepatitis C (CHC), in combination with other medicinal products.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kevin Allen Davis, MD 4301 W Markham St, Little Rock, AR 72205-7101 Ph: () - | Dr Kevin Allen Davis, MD 7301 Rogers Ave, Fort Smith, AR 72903-4100 Ph: (501) 593-3845 |
News Archive
So disease-causing bacteria in the body finally have multiplied to the point where their numbers are large enough to cause illness. What's next? They get out their "smart phones" and whisper "Let's roll!" That's how an article in ACS' monthly Chemical Reviews describes the substances "smart phones of the microbial world" that bacteria use to transmit chemical signals that launch infections and monitor their environment.
Researchers at The Ohio State University Ross Heart Hospital and Nationwide Children's Hospital have shown early treatment with the heart failure medication eplerenone can improve heart function in young boys with Duchenne muscular dystrophy (DMD) and stabilize heart function in older boys with the disease.
New research published in the November 4, 2008 issue of Neurology, the medical journal of the American Academy of Neurology, found that ADHD affects the motor skills of boys more than girls. By examining age-related improvement of motor skills in children with and without ADHD, researchers from the Kennedy Krieger Institute in Baltimore, Md. found that girls with ADHD and their typically developing peers were more likely to be able to control their movements compared to boys with ADHD.
Altair Therapeutics, Inc., a privately-held, biopharmaceutical company developing novel therapeutics for respiratory diseases, today announced the commencement of its IL-4 receptor alpha inhibitor bronchoprovocation trial. Study AIR645-CS2 is a phase 2, multi-center, randomized, double-blind, placebo-controlled study to assess the safety, tolerability, and efficacy of inhaled AIR645 in suppressing the asthmatic response in subjects with mild asthma. Results are expected in the third quarter of 2010.
Janssen-Cilag International NV today announced that its next generation protease inhibitor (PI) OLYSIOTM (simeprevir) has been granted marketing authorisation by the European Commission (EC) for the treatment of adults with genotype 1 and 4 chronic hepatitis C (CHC), in combination with other medicinal products.
› Verified 7 days ago
Dr. David A Hebert, M.D. Infectious Disease Medicare: Medicare Enrolled Practice Location: 7301 Rogers Ave, Fort Smith, AR 72903 Phone: 479-314-6000 | |
Christopher Brian Cross, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 6801 Rogers Ave, Fort Smith, AR 72903 Phone: 479-274-3200 Fax: 479-274-3289 | |
Fiorella Nawar, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1001 Towson Ave, Fort Smith, AR 72901 Phone: 479-709-7402 | |
Charles Moussallem, M.D Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1500 Dodson Ave, Suite 280, Fort Smith, AR 72901 Phone: 479-709-7480 Fax: 479-709-7479 | |
Dr. Jason Glenn Daily, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 6801 Rogers Ave, Fort Smith, AR 72903 Phone: 479-274-4000 Fax: 479-274-4099 | |
Ongkarn Sarasombath, M.D. Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 6801 Rogers Ave, Fort Smith, AR 72903 Phone: 479-274-2000 Fax: 479-274-2194 | |
Dr. Jacob K Joseph, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 6801 Rogers Ave, Fort Smith, AR 72903 Phone: 479-274-3200 Fax: 479-274-3289 |